Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Net Income (2020 - 2025)

Terns Pharmaceuticals filings provide 6 years of Net Income readings, the most recent being -$23.2 million for Q4 2025.

  • Quarterly Net Income fell 134.55% to -$23.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$95.9 million through Dec 2025, down 61155.41% year-over-year, with the annual reading at -$95.9 million for FY2025, 61155.41% down from the prior year.
  • Net Income hit -$23.2 million in Q4 2025 for Terns Pharmaceuticals, up from -$24.6 million in the prior quarter.
  • Across five years, Net Income topped out at $67.2 million in Q4 2024 and bottomed at -$29.8 million in Q3 2023.
  • Average Net Income over 5 years is -$12.3 million, with a median of -$19.5 million recorded in 2023.
  • The largest annual shift saw Net Income soared 420.23% in 2021 before it crashed 144.48% in 2022.
  • Terns Pharmaceuticals' Net Income stood at $35.6 million in 2021, then crashed by 144.48% to -$15.8 million in 2022, then crashed by 32.97% to -$21.0 million in 2023, then soared by 419.47% to $67.2 million in 2024, then plummeted by 134.55% to -$23.2 million in 2025.
  • Per Business Quant, the three most recent readings for TERN's Net Income are -$23.2 million (Q4 2025), -$24.6 million (Q3 2025), and -$24.1 million (Q2 2025).